Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Sellers

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Nurse Practitioner|January 1, 1997
Nurse practitioners coordinate clinical trialsM A Sellers, D J Shenkin, J Lavin-Tompkins
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral changes associated with different apolipoprotein E genotypes in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1996
APOE-related frequency of cognitive and noncognitive symptoms in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutationK M Kegley, M A Sellers, M J Ferber, et al.
Circulation|July 14, 1999
Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigationC S Rihal, K Sutton-Tyrrell, P Guo, et al.
Journal of the American College of Cardiology|September 14, 1999
Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)K A Burek, K Sutton-Tyrrell, M M Brooks, et al.
The American Journal of Cardiology|March 4, 1998
Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)K Sutton-Tyrrell, C Rihal, M A Sellers, et al.
American Heart Journal|October 31, 2000
Valsartan in acute myocardial infarction trial (VALIANT): rationale and designM A Pfeffer, J McMurray, A Leizorovicz, et al.
Quality & Safety in Health Care|August 13, 2010
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curveJ M Taekman, M Stafford-Smith, E J Velazquez, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Nurse Practitioner|January 1, 1997
Nurse practitioners coordinate clinical trialsM A Sellers, D J Shenkin, J Lavin-Tompkins
Alzheimer Disease and Associated Disorders|January 1, 1997
Behavioral changes associated with different apolipoprotein E genotypes in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
Annals of the New York Academy of Sciences|November 5, 1997
APOE epsilon 4 allele frequency in Alzheimer's disease and vascular dementia in the Spanish populationK Beyer, J I Lao, L Fernández-Novoa, et al.
Methods and Findings in Experimental and Clinical Pharmacology|December 1, 1996
APOE-related frequency of cognitive and noncognitive symptoms in dementiaR Cacabelos, B Rodríguez, C Carrera, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 30, 2010
Fulminant Wilson's disease requiring liver transplantation in one monozygotic twin despite identical genetic mutationK M Kegley, M A Sellers, M J Ferber, et al.
Circulation|July 14, 1999
Increased incidence of periprocedural complications among patients with peripheral vascular disease undergoing myocardial revascularization in the bypass angioplasty revascularization investigationC S Rihal, K Sutton-Tyrrell, P Guo, et al.
Journal of the American College of Cardiology|September 14, 1999
Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)K A Burek, K Sutton-Tyrrell, M M Brooks, et al.
The American Journal of Cardiology|March 4, 1998
Long-term prognostic value of clinically evident noncoronary vascular disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)K Sutton-Tyrrell, C Rihal, M A Sellers, et al.
American Heart Journal|October 31, 2000
Valsartan in acute myocardial infarction trial (VALIANT): rationale and designM A Pfeffer, J McMurray, A Leizorovicz, et al.
Quality & Safety in Health Care|August 13, 2010
Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curveJ M Taekman, M Stafford-Smith, E J Velazquez, et al.
Pageof 2